[go: up one dir, main page]

EP1836305A4 - Expression vectors for treating bacterial infections - Google Patents

Expression vectors for treating bacterial infections

Info

Publication number
EP1836305A4
EP1836305A4 EP04802302A EP04802302A EP1836305A4 EP 1836305 A4 EP1836305 A4 EP 1836305A4 EP 04802302 A EP04802302 A EP 04802302A EP 04802302 A EP04802302 A EP 04802302A EP 1836305 A4 EP1836305 A4 EP 1836305A4
Authority
EP
European Patent Office
Prior art keywords
expression vectors
bacterial infections
treating bacterial
treating
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04802302A
Other languages
German (de)
French (fr)
Other versions
EP1836305A1 (en
Inventor
Michael E Stiles
Belkum Marius Jacobus Van
Liru Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Canbiocin Inc
Original Assignee
Canbiocin Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canbiocin Inc filed Critical Canbiocin Inc
Publication of EP1836305A1 publication Critical patent/EP1836305A1/en
Publication of EP1836305A4 publication Critical patent/EP1836305A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Birds (AREA)
  • Microbiology (AREA)
  • Animal Husbandry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP04802302A 2004-12-14 2004-12-14 Expression vectors for treating bacterial infections Withdrawn EP1836305A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CA2004/002127 WO2006063425A1 (en) 2004-12-14 2004-12-14 Expression vectors for treating bacterial infections

Publications (2)

Publication Number Publication Date
EP1836305A1 EP1836305A1 (en) 2007-09-26
EP1836305A4 true EP1836305A4 (en) 2008-08-27

Family

ID=36587476

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04802302A Withdrawn EP1836305A4 (en) 2004-12-14 2004-12-14 Expression vectors for treating bacterial infections

Country Status (4)

Country Link
EP (1) EP1836305A4 (en)
CN (1) CN101111599B (en)
CA (1) CA2592344A1 (en)
WO (1) WO2006063425A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009011940A2 (en) * 2007-04-06 2009-01-22 University Of Maryland, Baltimore Microcin h47 plasmid selection system
CN103289944A (en) * 2012-03-01 2013-09-11 深圳市圣西马生物技术有限公司 Genetic engineering preparation method and application for streptococcus lactis secreting antibacterial peptide
CN110791509B (en) * 2019-11-18 2023-09-08 深圳市圣西马生物技术有限公司 Pediococcus acidilactici optimized expression sequence, expression vector, preparation method and strain thereof
CN119242550B (en) * 2024-12-06 2025-03-04 吉林农业大学 New functional lactic acid bacteria expressing ETEC antigens and preparation method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999002555A1 (en) * 1997-07-09 1999-01-21 The Governors Of The University Of Alberta Novel bacteriocins, transport and vector system and method of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0964693B1 (en) 1996-09-05 2010-04-14 The Governors Of The University Of Alberta Novel bacteriocins, transport and vector system and method of use thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999002555A1 (en) * 1997-07-09 1999-01-21 The Governors Of The University Of Alberta Novel bacteriocins, transport and vector system and method of use thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
FATH MICHAEL J ET AL: "Purification and characterization of colicin V from Escherichia coli culture supernatants", BIOCHEMISTRY, vol. 33, no. 22, 1994, pages 6911 - 6917, XP002487338, ISSN: 0006-2960 *
MCCORMICK J K ET AL: "Colicin V can be produced by lactic acid bacteria", LETTERS IN APPLIED MICROBIOLOGY, OXFORD, GB, vol. 29, no. 1, 1 July 1999 (1999-07-01), pages 37 - 41, XP002336015, ISSN: 1472-765X *
See also references of WO2006063425A1 *
VAN BELKUM MARCO J ET AL: "Double-glycine-type leader peptides direct secretion of bacteriocins by ABC transporters: Colicin V secretion in Lactococcus lactis", MOLECULAR MICROBIOLOGY, BLACKWELL SCIENTIFIC, OXFORD, vol. 23, no. 6, 1 January 1997 (1997-01-01), pages 1293 - 1301, XP002321731, ISSN: 0950-382X *

Also Published As

Publication number Publication date
WO2006063425A1 (en) 2006-06-22
CN101111599A (en) 2008-01-23
EP1836305A1 (en) 2007-09-26
CA2592344A1 (en) 2006-06-22
CN101111599B (en) 2013-01-23

Similar Documents

Publication Publication Date Title
SI2987796T1 (en) Halogen-substituted boronophthalides for the treatment of infections
EP2015755A4 (en) Improvements in therapy for treating resistant bacterial infections
ZA200906349B (en) Combination medicaments for treating bacterial infections
ZA200710563B (en) Compounds for the treatment of multi-drug resistant bacterial infections
IL184955A0 (en) Tricyclic-nucleoside compounds for treating viral infections
PL1755661T3 (en) Gelsolin for use in treating infections
IL183889A0 (en) Treatment method
WO2007118130A3 (en) Antibacterial agents
IL178207A0 (en) Dalbavancin compositions for treatment of bacterial infections
GB0324189D0 (en) Short-channel transistors
GB0513096D0 (en) Treatment of microbial infections
GB0411428D0 (en) Vectors
PT2081594E (en) Novel method for treating h.pylori infections
EP2004837A4 (en) Neutralizing agents for bacterial toxins
EP1883405A4 (en) Methods for treating nephrolithiasis
EP1836305A4 (en) Expression vectors for treating bacterial infections
GB0414886D0 (en) Treatment of bacterial infections
GB2407249B (en) Yoghurt processing
EP1709967A4 (en) Agents for treating migraine
HK1100327A (en) Treatment of bacterial infections
GB0301017D0 (en) Anti bacterial composition uses
AU2004900839A0 (en) Bacterial treatment
AU2004907245A0 (en) Bacterial treatment
GB0514849D0 (en) Treatment for kerationlytic and other fungal infections
HK1116495A (en) Novel method for preventing or treating m tuberculosis infection

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070713

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20080730

17Q First examination report despatched

Effective date: 20081128

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120320